Mustang Bio Inc. [MBIO] Stock trading around $3.16 per share: What’s Next?

Mustang Bio Inc. [NASDAQ: MBIO] loss -7.06% on the last trading session, reaching $3.16 price per share at the time. Mustang Bio Inc. represents 41.97 million in outstanding shares, while the company has a total market value of $140.15 million with the latest information. MBIO stock price has been found in the range of $3.04 to $3.59.

If compared to the average trading volume of 532.16K shares, MBIO reached a trading volume of 3167393 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Mustang Bio Inc. [MBIO]:

Cantor Fitzgerald have made an estimate for Mustang Bio Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on November 20, 2019. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on August 13, 2019, representing the official price target for Mustang Bio Inc. stock. Previously, the target price had yet another raise to $7, while Cantor Fitzgerald analysts kept a Overweight rating on MBIO stock.

The Average True Range (ATR) for Mustang Bio Inc. is set at 0.41 The Price to Book ratio for the last quarter was 2.90.

Trading performance analysis for MBIO stock

Mustang Bio Inc. [MBIO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -31.30. With this latest performance, MBIO shares gained by 12.46% in over the last four-week period, additionally plugging by 3.95% over the last 6 months – not to mention a drop of -16.84% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MBIO stock in for the last two-week period is set at 44.38, with the RSI for the last a single of trading hit 40.11, and the three-weeks RSI is set at 47.39 for Mustang Bio Inc. [MBIO]. The present Moving Average for the last 50 days of trading for this stock 3.15, while it was recorded at 3.24 for the last single week of trading, and 3.28 for the last 200 days.

Mustang Bio Inc. [MBIO]: A deeper dive into fundamental analysis

Return on Total Capital for MBIO is now -88.60, given the latest momentum, and Return on Invested Capital for the company is -90.90. Return on Equity for this stock declined to -105.37, with Return on Assets sitting at -79.84. When it comes to the capital structure of this company, Mustang Bio Inc. [MBIO] has a Total Debt to Total Equity ratio set at 30.06. Additionally, MBIO Total Debt to Total Capital is recorded at 23.12, with Total Debt to Total Assets ending up at 21.14. Long-Term Debt to Equity for the company is recorded at 27.15, with the Long-Term Debt to Total Capital now at 20.87.

Reflecting on the efficiency of the workforce at the company, Mustang Bio Inc. [MBIO] managed to generate an average of -$909,588 per employee.Mustang Bio Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.80 and a Current Ratio set at 5.80.

Mustang Bio Inc. [MBIO]: An earnings per share (EPS) analysis

With the latest financial reports released by the company, Mustang Bio Inc. posted -0.29/share EPS, while the average EPS was predicted by analysts to be reported at -0.25/share.When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -16.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MBIO.

An analysis of insider ownership at Mustang Bio Inc. [MBIO]

There are presently around $32 million, or 21.50% of MBIO stock, in the hands of institutional investors. The top three institutional holders of MBIO stocks are: BLACKROCK INC. with ownership of 1,940,322, which is approximately 0.01% of the company’s market cap and around 1.10% of the total institutional ownership; VANGUARD GROUP INC, holding 1,382,467 shares of the stock with an approximate value of $4.7 million in MBIO stocks shares; and RENAISSANCE TECHNOLOGIES LLC, currently with $2.81 million in MBIO stock with ownership of nearly 7.706% of the company’s market capitalization.

29 institutional holders increased their position in Mustang Bio Inc. [NASDAQ:MBIO] by around 1,111,450 shares. Additionally, 24 investors decreased positions by around 595,570 shares, while 16 investors held positions by with 7,582,471 shares. The mentioned changes placed institutional holdings at 9,289,491 shares, according to the latest SEC report filing. MBIO stock had 13 new institutional investments in for a total of 792,335 shares, while 6 institutional investors sold positions of 72,210 shares during the same period.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on skype
Skype
Share on reddit
Reddit

Leave a Comment

Your email address will not be published. Required fields are marked *

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.